Etomidate Injection Shortage

• • Amidate injection, Pfizer, 2 mg/mL, 20 mL LifeShield syringe, 10 count, NDC 00409-8060-29 - discontinued

• • American Regent is not currently marketing etomidate.
  • Athenex is no longer marketing etomidate injection.
  • AuroMedics had etomidate injection on shortage due to increased demand.
  • Fosun Pharma has etomidate injection available.
  • Hikma has etomidate injection on shortage due to increased demand.
  • Mylan Institutional has etomidate available.
  • Par Sterile Products discontinued etomidate in early 2015.
  • Pfizer discontinued etomidate ampules in October 2016. The LifeShield syringes were discontinued in August 2020.
  • Sagent is no longer marketing etomidate.
  • Zydus discontinued etomidate .

• • Amidate injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-6695-01
  • Amidate injection, Pfizer, 2 mg/mL, 20 mL vial, 10 count, NDC 00409-6695-02
  • Etomidate injection, AuroMedics, 2 mg/mL, 10 mL vial, 10 count, NDC 55150-0221-10
  • Etomidate injection, AuroMedics, 2 mg/mL, 20 mL vial, 10 count, NDC 55150-0222-20
  • Etomidate solution for injection, Fosun Pharma, 2 mg/mL, 10 mL vial, 10 count, NDC 72266-0146-10
  • Etomidate solution for injection, Fosun Pharma, 2 mg/mL, 20 mL vial, 10 count, NDC 72266-0147-10
  • Etomidate injection, Hikma, 2 mg/mL, 10 mL vial, 10 count, NDC 00143-9506-10
  • Etomidate injection, Hikma, 2 mg/mL, 20 mL vial, 10 count, NDC 00143-9507-10
  • Etomidate injection, Mylan Institutional, 2 mg/mL, 10 mL vial, 10 count, NDC 67457-0902-10
  • Etomidate injection, Mylan Institutional, 2 mg/mL, 20 mL vial, 10 count, NDC 67457-0903-20

Estimated Resupply Dates

• • All marketed presentations are available.

Safety

• • Clinicians must take extra care to ensure safe use of etomidate when using different presentations than those normally stocked.